← Back to catalogue

Dermagraft

FDA UDI

Class III (US FDA UDI)

by Organogenesis Inc.

Identity

Trade Name
Dermagraft FDA UDI
Generic Name
Skin regeneration template, human-/animal-derived FDA UDI
Device Name
Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients that have adequate blood supply to the involved foot. FDA UDI
Model / Reference
1 FDA UDI
Description
Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients that have adequate blood supply to the involved foot. FDA UDI

Identifiers

Primary DI / UDI-DI
00618474000015 FDA UDI
FDA Product Code
PFC FDA UDI
GMDN Term
Skin regeneration template, human-/animal-derived FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

Yes

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Skin regeneration template, human-/animal-derived

Dermagraft by Organogenesis Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Skin regeneration template, human-/animal-derived.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Organogenesis Inc.

Sources (1)

  • FDA UDI 17ff0e99-7199-44d1-b844-9bde6d4ca4e7 36 fields · synced Jun 8, 2026